Patents by Inventor Douglas Pat Cerretti

Douglas Pat Cerretti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Human C-FMS antigen binding proteins
    Patent number: 9988457
    Abstract: Antigen binding proteins that bind to human c-fms protein are provided. Nucleic acids encoding the antigen binding protein, vectors, and cells encoding the same are also provided. The antigen binding proteins can inhibit binding of c-fms to CSF-1, reduce monocyte migration into tumors, and reduce the accumulation of tumor-associated macrophages.
    Type: Grant
    Filed: February 19, 2016
    Date of Patent: June 5, 2018
    Assignee: AMGEN INC.
    Inventors: Kenneth Allan Brasel, James F. Smothers, Douglas Pat Cerretti
  • HUMAN C-FMS ANTIGEN BINDING PROTEINS
    Publication number: 20160340434
    Abstract: Antigen binding proteins that bind to human c-fms protein are provided. Nucleic acids encoding the antigen binding protein, vectors, and cells encoding the same are also provided. The antigen binding proteins can inhibit binding of c-fms to CSF-1, reduce monocyte migration into tumors, and reduce the accumulation of tumor-associated macrophages.
    Type: Application
    Filed: February 19, 2016
    Publication date: November 24, 2016
    Applicant: Amgen Inc.
    Inventors: Kenneth Allan BRASEL, James F. SMOTHERS, Douglas Pat CERRETTI
  • Human C-FMS antibodies
    Patent number: 9303084
    Abstract: Antigen binding proteins that bind to human c-fms protein are provided. Nucleic acids encoding the antigen binding protein, vectors, and cells encoding the same are also provided. The antigen binding proteins can inhibit binding of c-fms to CSF-1, reduce monocyte migration into tumors, and reduce the accumulation of tumor-associated macrophages.
    Type: Grant
    Filed: August 14, 2013
    Date of Patent: April 5, 2016
    Assignee: AMGEN INC.
    Inventors: Kenneth Allan Brasel, James F Smothers, Douglas Pat Cerretti
  • HUMAN C-FMS ANTIGEN BINDING PROTEINS
    Publication number: 20140105916
    Abstract: Antigen binding proteins that bind to human c-fms protein are provided. Nucleic acids encoding the antigen binding protein, vectors, and cells encoding the same are also provided. The antigen binding proteins can inhibit binding of c-fms to CSF-1, reduce monocyte migration into tumors, and reduce the accumulation of tumor-associated macrophages.
    Type: Application
    Filed: August 14, 2013
    Publication date: April 17, 2014
    Applicant: AMGEN INC.
    Inventors: Kenneth Allan BRASEL, James F SMOTHERS, Douglas Pat CERRETTI
  • Methods for treating conditions associated with c-fms
    Patent number: 8513199
    Abstract: Antigen binding proteins that bind to human c-fms protein are provided. Nucleic acids encoding the antigen binding protein, vectors, and cells encoding the same are also provided. The antigen binding proteins can inhibit binding of c-fms to CSF-1, reduce monocyte migration into tumors, and reduce the accumulation of tumor-associated macrophages.
    Type: Grant
    Filed: May 8, 2012
    Date of Patent: August 20, 2013
    Assignee: Amgen Inc.
    Inventors: Kenneth Allan Brasel, James F Smothers, Douglas Pat Cerretti
  • METHODS FOR TREATING CONDITIONS ASSOCIATED WITH C-FMS
    Publication number: 20120230987
    Abstract: Antigen binding proteins that bind to human c-fms protein are provided. Nucleic acids encoding the antigen binding protein, vectors, and cells encoding the same are also provided. The antigen binding proteins can inhibit binding of c-fms to CSF-1, reduce monocyte migration into tumors, and reduce the accumulation of tumor-associated macrophages.
    Type: Application
    Filed: May 8, 2012
    Publication date: September 13, 2012
    Applicant: AMGEN INC.
    Inventors: Kenneth Allan BRASEL, James F. SMOTHERS, Douglas Pat CERRETTI, Christopher MEHLIN, Jilin SUN, Stephen FOSTER
  • Human C-FMS antigen binding proteins
    Patent number: 8182813
    Abstract: Antigen binding proteins that bind to human c-fms protein are provided. Nucleic acids encoding the antigen binding protein, vectors, and cells encoding the same are also provided. The antigen binding proteins can inhibit binding of c-fms to CSF-1, reduce monocyte migration into tumors, and reduce the accumulation of tumor-associated macrophages.
    Type: Grant
    Filed: August 20, 2008
    Date of Patent: May 22, 2012
    Assignee: Amgen Inc.
    Inventors: Kenneth Allan Brasel, James F. Smothers, Douglas Pat Cerretti
  • HUMAN C-FMS ANTIGEN BINDING PROTEINS
    Publication number: 20090155164
    Abstract: Antigen binding proteins that bind to human c-fms protein are provided. Nucleic acids encoding the antigen binding protein, vectors, and cells encoding the same are also provided. The antigen binding proteins can inhibit binding of c-fms to CSF-1, reduce monocyte migration into tumors, and reduce the accumulation of tumor-associated macrophages.
    Type: Application
    Filed: August 20, 2008
    Publication date: June 18, 2009
    Applicant: Amgen, Inc.
    Inventors: Kenneth Allan Brasel, James F. Smothers, Douglas Pat Cerretti, Christopher Mehlin, Jilin Sun, Stephen Foster
  • SVPH1-26 DNA and polypeptides
    Publication number: 20090017492
    Abstract: DNA encoding SVPH1-26 polypeptides and methods for using the encoded proteinase and polypeptides are disclosed. SVPH1-26 is expressed in testis.
    Type: Application
    Filed: June 15, 2007
    Publication date: January 15, 2009
    Applicant: Immunex Corporation
    Inventor: Douglas Pat Cerretti
  • ADAM20 (SVPH1-26) DNA and polypeptides
    Publication number: 20040053314
    Abstract: DNA encoding SVPH1-26 polypeptides and methods for using the encoded proteinase and polypeptides are disclosed. SVPH1-26 is expressed in testis.
    Type: Application
    Filed: July 29, 2003
    Publication date: March 18, 2004
    Applicant: Immunex Corporation
    Inventor: Douglas Pat Cerretti